Jaber, Samir
Bellani, Giacomo
Blanch, Lluis
Demoule, Alexandre
Esteban, Andrés
Gattinoni, Luciano
Guérin, Claude
Hill, Nicholas
Laffey, John G.
Maggiore, Salvatore Maurizio
Mancebo, Jordi
Mayo, Paul H.
Mosier, Jarrod M.
Navalesi, Paolo
Quintel, Michael
Vincent, Jean Louis
Marini, John J.
Article History
Received: 8 February 2017
Accepted: 20 July 2017
First Online: 7 August 2017
Compliance with ethical standards
:
: Dr Blanch is inventor of a US patent owned by Corporació Sanitaria Parc Taulí: “Method and system for managing related patient parameters provided by a monitoring device,” US Patent No. 12/538,940. He owns stock options in BetterCare S.L., a research and development start-up of Corporació Sanitària Parc Taulí (Spain). Dr Demoule reports personal fees from Maquet, grants, personal fees, and non-financial support from Covidien, personal fees from MSD, grants and non-financial support from Philips, non-financial support from Drager, grants from Resmed, and personal fees from Fisher and Paykel, all outside the submitted work. Dr Jaber reports receiving consulting fees from Drager, Hamilton, Maquet, and Fisher and Paykel. Dr Maggiore is the principal investigator of the RINO trial (nasal high-flow vs Venturi mask after extubation), sponsored by Fisher and Paykel Healthcare, and has received research grants from Fisher and Paykel Healthcare and lecture fees from Draeger Medical and GE Healthcare. Dr Mancebo reports the following: Covidien and Maquet—research support; Faron—steering committee member; Covidien and Hamilton—honoraria for speaking at a meeting. Dr. Navalesi’s research laboratory has received equipment and grants from Maquet Critical Care, Draeger, and Intersurgical S.p.A. He has also received honoraria/speaking fees from Maquet Critical Care, Draeger, Breas, Philips, Resmed, and Hillrom. Dr Navalesi contributed to the development of the helmet Next, whose license for patent belongs to Intersurgical S.p.A., and receives royalties for that invention. Dr Quintel acts as advisor for Xenios and Baxter. CG, JGL, JJM, JMM, PM, and JLV declare no conflict of interest.
Free to read: This content has been made available to all.